Chen-Hsuan Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chen-Hsuan Lin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jih-Jin Tsai
School of Medicine, College of Medicine, Kaohsiung Medical University
3 shared publications - Li-Teh Liu
Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan City, Taiwan
3 shared publications - Ching-Yi Tsai
Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
2 shared publications Chun-Hong Chen
National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Zhunan, Miaoli County, Taiwan; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Miaoli County, Taiwan
2 shared publicationsPo-Chih Chen
Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung City, Taiwan
2 shared publicationsChang‐Chi Lin
Institute of Preventive Medicine National Defense Medical Center Taipei Taiwan
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8)
Association Between Chikungunya Infection and Rheumatoid Arthritis in Taiwan—A Cross‐Sectional Study
Objectives: Chikungunya virus (CHIKV) infection might cause chronic chikungunya arthritis resembling rheumatoid arthritis (RA). The purpose of this study is to investigate the potential role of this virus in the pathogenesis of RA in Taiwan, a non‐endemic area. Methods: This cross‐sectional study enrolled 98 RA patients and 200 healthy controls. Serum CHIKV IgM and IgG were tested using two commercial enzyme‐linked immunosorbent assay (ELISA) kits (Abcam and Euroimmun) and an in‐house neutralization assay. ELISA‐IgM was performed only in patients with RA. ELISA or neutralization positive samples were further tested for CHIKV RNA by reverse‐transcription‐polymerase chain reaction. Associations between CHIKV seropositivity and various autoantibodies were analyzed. The agreements among these assays were also evaluated. Results: Neutralizing antibodies were detected in 2 of 98 RA patients and in none of the controls ( p = 0.107, Fisher's exact test; p = 0.043, chi‐square). Both patients were absent from Abcam‐IgM and ‐IgG, as well as Euroimmun‐IgM and ‐IgG testing. There was no association between Abcam‐IgM or Euroimmun‐IgM and rheumatoid factor, anti‐cyclic citrullinated peptide, antinuclear, or anti‐extractable nuclear antigen antibodies. Poor agreements were noted between the neutralizing assay and Abcam‐IgG or Euroimmun‐IgG ( κ = 0 and 0, respectively). A similar finding was also found between Abcam‐IgM and Euroimmun‐IgM ( κ = −0.38). Conclusion: Our study was not sufficiently powered to establish a causal association between CHIKV infection and RA development. Poor agreements were noted among different commercial ELISA kits and neutralization assays, underscoring the limitations of the serology assay.
- 5 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8)
Open AccessAssociation Between Chikungunya Infection and Rheumatoid Arthritis in Taiwan—A Cross‐Sectional Study
Objectives: Chikungunya virus (CHIKV) infection might cause chronic chikungunya arthritis resembling rheumatoid arthritis (RA). The purpose of this study is to investigate the potential role of this virus in the pathogenesis of RA in Taiwan, a non‐endemic area. Methods: This cross‐sectional study enrolled 98 RA patients and 200 healthy controls. Serum CHIKV IgM and IgG were tested using two commercial enzyme‐linked immunosorbent assay (ELISA) kits (Abcam and Euroimmun) and an in‐house neutralization assay. ELISA‐IgM was performed only in patients with RA. ELISA or neutralization positive samples were further tested for CHIKV RNA by reverse‐transcription‐polymerase chain reaction. Associations between CHIKV seropositivity and various autoantibodies were analyzed. The agreements among these assays were also evaluated. Results: Neutralizing antibodies were detected in 2 of 98 RA patients and in none of the controls ( p = 0.107, Fisher's exact test; p = 0.043, chi‐square). Both patients were absent from Abcam‐IgM and ‐IgG, as well as Euroimmun‐IgM and ‐IgG testing. There was no association between Abcam‐IgM or Euroimmun‐IgM and rheumatoid factor, anti‐cyclic citrullinated peptide, antinuclear, or anti‐extractable nuclear antigen antibodies. Poor agreements were noted between the neutralizing assay and Abcam‐IgG or Euroimmun‐IgG ( κ = 0 and 0, respectively). A similar finding was also found between Abcam‐IgM and Euroimmun‐IgM ( κ = −0.38). Conclusion: Our study was not sufficiently powered to establish a causal association between CHIKV infection and RA development. Poor agreements were noted among different commercial ELISA kits and neutralization assays, underscoring the limitations of the serology assay.
- Open Access
- 29 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (2) , 103075
Genomic evolution and epidemiological impact of SARS-CoV-2 omicron subvariants in Taiwan, 2023–2025
- 29 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (2) , 103075
Open AccessGenomic evolution and epidemiological impact of SARS-CoV-2 omicron subvariants in Taiwan, 2023–2025
- Open Access
- 6 August 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (11) , 102919
Performance comparison of two dengue NS1 rapid diagnostic tests against RT-PCR: Sensitivity and specificity across infections and timeframes
- 6 August 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (11) , 102919
Open AccessPerformance comparison of two dengue NS1 rapid diagnostic tests against RT-PCR: Sensitivity and specificity across infections and timeframes